StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
667
This month
9
This week
2
This year
71
Yesterday
2
Publishing Date
2024 - 03 - 11
5
2024 - 01 - 24
3
2024 - 01 - 12
4
2024 - 01 - 08
3
2023 - 12 - 12
3
2023 - 12 - 01
3
2023 - 10 - 23
5
2023 - 09 - 11
4
2023 - 08 - 25
3
2023 - 06 - 28
3
2023 - 06 - 05
3
2023 - 04 - 13
4
2023 - 02 - 13
4
2023 - 02 - 02
3
2022 - 12 - 07
3
2022 - 12 - 06
5
2022 - 11 - 28
4
2022 - 09 - 26
3
2022 - 09 - 19
4
2022 - 08 - 02
3
2022 - 07 - 25
3
2022 - 06 - 27
3
2022 - 06 - 17
3
2022 - 06 - 03
4
2022 - 05 - 25
3
2022 - 05 - 17
3
2022 - 05 - 16
5
2022 - 05 - 05
3
2022 - 04 - 26
3
2022 - 03 - 22
3
2022 - 03 - 21
3
2022 - 03 - 03
3
2022 - 03 - 01
3
2022 - 02 - 22
3
2022 - 02 - 18
3
2022 - 02 - 10
3
2022 - 02 - 07
3
2021 - 11 - 24
3
2021 - 10 - 04
3
2021 - 09 - 17
3
2021 - 08 - 12
4
2021 - 08 - 05
6
2021 - 07 - 28
2
2021 - 07 - 08
2
2021 - 06 - 25
2
2021 - 06 - 18
2
2021 - 06 - 16
2
2021 - 06 - 11
2
2021 - 06 - 10
3
2021 - 06 - 09
2
2021 - 05 - 12
2
2021 - 05 - 11
2
2021 - 05 - 10
2
2021 - 04 - 30
2
2021 - 04 - 21
2
2021 - 04 - 20
2
2021 - 03 - 18
2
2021 - 03 - 16
2
2021 - 03 - 12
2
2021 - 03 - 04
3
Sector
Commercial services
7
Communications
4
Consumer non-durables
8
Consumer services
2
Distribution services
2
Electronic technology
7
Finance
5
Health services
10
Health technology
667
Industrial services
1
Information
2
Manufacturing
66
Mining, quarrying, and oil and gas extraction
2
N/a
32
Non-energy minerals
1
Process industries
11
Producer manufacturing
14
Professional, scientific, and technical services
12
Retail trade
2
Technology services
7
Tags
Agreement
11
Alliances
24
America
28
Antibody
19
Astrazeneca
15
Biotech
28
Breast
11
Breast cancer
13
Cancer
144
Cell
14
Clinical-trials-phase-iii
16
Collaboration
14
Covid-19
8
Diabetes
16
Diagnostic
10
Diagnostics
11
Disease
34
Drug
70
Drug delivery
12
Enhertu
24
Europe
11
Expected
13
Fda
9
Financial
10
Financial results
9
Global
108
Granted
8
Growing
24
Growth
120
Health
9
Her2
27
Her2-
18
Immunotherapy
10
Iot
8
Key
9
License
16
Liver
18
Lung
24
Lung cancer
10
Market
267
Metastatic breast cancer
11
N/a
516
Partnership
8
People
10
Pharma
10
Positive
13
Reach
20
Report
95
Research
73
Respiratory
12
Results
30
Review
11
Set
16
System
9
Technology
10
Therapeutics
71
Therapy
32
Treatment
46
Trial
52
Vaccine
29
Entities
3m company
13
Abbott laboratories
84
Abbvie inc.
100
Adaptimmune therapeutics plc
4
Agilent technologies, inc.
4
Alkermes plc
5
Amgen inc.
106
Aptargroup, inc.
6
Artelo biosciences, inc.
17
Astellas pharma inc
42
Astrazeneca plc
667
Avenue therapeutics, inc.
7
Aveo pharmaceuticals, inc.
6
Bausch health companies inc.
12
Baxter international inc.
27
Becton, dickinson and company
7
Biogen inc.
22
Biomarin pharmaceutical inc.
4
Biontech se
8
Boston scientific corporation
5
Bristol-myers squibb company
61
Checkpoint therapeutics, inc.
5
Compugen ltd.
7
Csl ltd
14
Eli lilly and company
98
Endo international plc
9
Fibrogen, inc
4
Fortress biotech, inc.
31
Fusion pharmaceuticals inc.
4
Galapagos nv
8
Genprex, inc.
9
Gilead sciences, inc.
10
Glaxosmithkline plc
191
Hutchison china meditech limited
11
Illumina, inc.
7
Innate pharma s.a.
4
Innate pharma sa
4
Insulet corporation
4
Ionis pharmaceuticals, inc.
4
Jazz pharmaceuticals plc
5
Johnson & johnson
117
Journey medical corp
6
Koninklijke philips n.v.
11
Medtronic plc
14
Mitsubishi chemical holdings corp
5
Moderna, inc.
5
Mustang bio, inc.
6
Neurocrine biosciences, inc.
5
Novartis ag
199
Novo nordisk a/s
30
Pfizer, inc.
45
Puma biotechnology inc
6
Reckitt benckiser group plc
6
Regeneron pharmaceuticals, inc.
5
Sanofi
214
Takeda pharmaceutical company limited
29
Teva pharmaceutical industries limited
7
Teva pharmaceutical industries ltd
85
Thermo fisher scientific inc
19
Viatris inc.
32
Symbols
AAPL
1198
ABB
1433
ABBV
1029
ABLZF
1172
ABT
1795
ACN
602
AMGN
744
ARVL
4301
AVGO
597
AZN
667
BDX
796
BMY
662
BNPQF
1765
BNPQY
1765
CSCO
899
DHR
786
ERIC
1614
F
643
FNCTF
7207
FRBA
600
GE
918
GLAXF
661
GOOG
1294
GOOGL
1293
GSK
887
HON
1791
HUBS
1400
IBM
655
INTC
955
IT
595
JNJ
4590
LLY
1710
LTUM
971
LYV
717
MDT
1285
MMM
938
MS
4289
MSFT
1202
MT
591
NOK
902
NOKBF
978
NVO
634
NVS
1243
NVSEF
1033
ORCL
1160
PCRFF
651
PCRFY
651
PFE
693
PHG
963
PPRUF
1129
PPRUY
1130
SAP
1480
SAPGF
1234
SNOW
796
SNY
4546
SNYNF
3604
TEVJF
632
TMO
1626
VZ
1218
XYF
678
Exchanges
Amex
5
Nasdaq
667
Nyse
410
Crawled Date
2024 - 03 - 11
5
2024 - 01 - 30
3
2024 - 01 - 24
3
2024 - 01 - 12
4
2024 - 01 - 08
3
2023 - 12 - 19
3
2023 - 12 - 12
3
2023 - 10 - 23
5
2023 - 09 - 11
4
2023 - 08 - 25
3
2023 - 06 - 28
3
2023 - 06 - 05
3
2023 - 04 - 13
4
2023 - 02 - 14
3
2023 - 02 - 13
3
2023 - 02 - 02
3
2022 - 12 - 07
3
2022 - 12 - 06
5
2022 - 11 - 28
3
2022 - 09 - 26
3
2022 - 09 - 19
4
2022 - 08 - 02
3
2022 - 07 - 25
3
2022 - 06 - 27
3
2022 - 06 - 17
3
2022 - 06 - 03
4
2022 - 05 - 25
3
2022 - 05 - 17
3
2022 - 05 - 16
5
2022 - 05 - 05
3
2022 - 04 - 26
3
2022 - 03 - 22
3
2022 - 03 - 21
3
2022 - 03 - 03
3
2022 - 03 - 02
3
2022 - 02 - 22
3
2022 - 02 - 18
3
2022 - 02 - 10
3
2022 - 02 - 07
3
2021 - 11 - 24
3
2021 - 10 - 04
3
2021 - 09 - 17
3
2021 - 08 - 12
4
2021 - 08 - 05
6
2021 - 07 - 28
3
2021 - 06 - 18
2
2021 - 06 - 16
2
2021 - 06 - 11
2
2021 - 06 - 10
3
2021 - 06 - 09
2
2021 - 05 - 12
2
2021 - 05 - 11
2
2021 - 05 - 10
2
2021 - 04 - 30
2
2021 - 04 - 21
2
2021 - 04 - 20
2
2021 - 03 - 18
2
2021 - 03 - 16
2
2021 - 03 - 12
2
2021 - 03 - 04
3
Crawled Time
00:00
19
00:20
5
01:00
19
01:12
1
02:00
15
03:00
13
03:10
1
04:00
13
04:20
9
05:00
8
06:00
13
07:00
18
08:00
16
09:00
25
09:07
1
10:00
17
11:00
36
12:00
39
12:15
2
12:20
11
12:30
6
13:00
27
13:02
1
13:15
5
13:20
8
13:30
8
13:37
1
14:00
33
14:15
3
14:20
6
14:30
7
15:00
29
15:15
3
15:20
9
15:30
9
16:00
34
16:20
2
17:00
34
18:00
27
19:00
33
19:11
1
20:00
24
21:00
22
21:03
1
22:00
25
23:00
27
23:09
1
Source
investor.aveooncology.com
2
ir.chemocentryx.com
1
www.biospace.com
151
www.chi-med.com
2
www.globenewswire.com
70
www.prnewswire.com
440
www.sutrobio.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Azn
save search
Global Cardiovascular and Cerebrovascular Diseases Market Research Analysis 2023-2029: Sizeable Cardiovascular Market Shows Slower Growth Amid Patent Expirations and Generics' Rise
Published:
2023-08-30
(Crawled : 15:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
1.86%
-4.19%
3.6K
|
Health Technology
|
-0.27%
|
O:
0.56%
H:
0.0%
C:
-2.26%
JNJ
|
News
|
$149.12
0.82%
0.3%
7.2M
|
Health Technology
|
-9.45%
|
O:
0.56%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.07
-0.2%
-0.09%
3.8M
|
Health Technology
|
3.62%
|
O:
0.73%
H:
0.96%
C:
0.32%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-14.3%
|
O:
0.66%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
1.43%
|
O:
0.46%
H:
0.17%
C:
-0.86%
patent
research
global
cardiovascular
growth
market
Empowering Healthcare: Global Vaccine Management System Market to Reach $441.17 million by 2028
Published:
2023-08-30
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
0.52%
-14.18%
630
|
Health Technology
|
12.34%
|
O:
-1.57%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.73
1.86%
-4.19%
3.6K
|
Health Technology
|
-0.27%
|
O:
0.56%
H:
0.0%
C:
-2.26%
NVS
|
News
|
$95.12
0.81%
5.43%
2.3M
|
Health Technology
|
-8.24%
|
O:
-0.25%
H:
0.47%
C:
-1.08%
JNJ
|
News
|
$149.12
0.82%
0.3%
7.2M
|
Health Technology
|
-9.45%
|
O:
0.56%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.59
2.11%
0.57%
3.5M
|
Health Technology
|
14.31%
|
O:
0.54%
H:
0.27%
C:
-0.59%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-14.3%
|
O:
0.66%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
1.43%
|
O:
0.46%
H:
0.17%
C:
-0.86%
management
vaccine
reach
global
system
market
Global Digital Dose Inhaler Market Primed for Remarkable Growth, Forecasted to Reach $53.32 Billion by 2030
Published:
2023-08-25
(Crawled : 19:00)
- prnewswire.com
OPK
|
$1.23
0.0%
1.9M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$40.59
2.11%
0.57%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
MMM
|
$92.62
0.38%
0.0%
2.3M
|
Producer Manufacturing
|
Email alert
Add to watchlist
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$95.12
0.81%
5.43%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.73
1.86%
-4.19%
3.6K
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.305
0.52%
-14.18%
630
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$95.11
5.4%
6.88%
490
|
Health Technology
|
Email alert
Add to watchlist
reach
global
market
Minimal Residual Disease Testing Global Markets and Technology Research Report 2023-2028: Charting Cancer Treatment Trajectories - The Role of MRD Explored
Published:
2023-08-25
(Crawled : 14:30)
- prnewswire.com
AZNCF
|
News
|
$138.73
1.86%
-4.19%
3.6K
|
Health Technology
|
2.01%
|
O:
-3.27%
H:
3.65%
C:
3.36%
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
3.3%
|
O:
0.22%
H:
0.6%
C:
0.31%
AMGN
|
News
|
$271.91
1.11%
1.12%
1.4M
|
Health Technology
|
5.96%
|
O:
0.19%
H:
0.25%
C:
-0.28%
disease
report
cancer
treatment
research
global
technology
Global Autoimmune Treatment Market Soars to $288.32 Billion by 2028, Driven by a 7.72% CAGR from 2023
Published:
2023-08-25
(Crawled : 02:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
1.86%
-4.19%
3.6K
|
Health Technology
|
2.01%
|
O:
-3.27%
H:
3.65%
C:
3.36%
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
-36.34%
|
O:
-4.14%
H:
5.37%
C:
4.39%
NVS
|
News
|
$95.12
0.81%
5.43%
2.3M
|
Health Technology
|
-6.02%
|
O:
0.67%
H:
0.37%
C:
0.26%
JNJ
|
News
|
$149.12
0.82%
0.3%
7.2M
|
Health Technology
|
-9.08%
|
O:
0.51%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$167.89
0.89%
0.0%
5.6M
|
Health Technology
|
14.08%
|
O:
-0.11%
H:
0.44%
C:
-0.22%
ABT
|
News
|
$107.07
-0.2%
-0.09%
3.8M
|
Health Technology
|
1.96%
|
O:
-0.73%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
3.3%
|
O:
0.22%
H:
0.6%
C:
0.31%
AMGN
|
News
|
$271.91
1.11%
1.12%
1.4M
|
Health Technology
|
5.96%
|
O:
0.19%
H:
0.25%
C:
-0.28%
treatment
global
market
Global Nasal Drug Delivery Technology Market Projected to Reach $111.9 Billion by 2030
Published:
2023-08-23
(Crawled : 22:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
0.52%
-14.18%
630
|
Health Technology
|
18.89%
|
O:
1.41%
H:
1.07%
C:
-1.39%
AZNCF
|
News
|
$138.73
1.86%
-4.19%
3.6K
|
Health Technology
|
-0.44%
|
O:
-3.15%
H:
0.77%
C:
0.77%
PFE
|
News
A
|
$26.26
1.0%
-0.08%
36M
|
Health Technology
|
-28.37%
|
O:
-0.5%
H:
0.45%
C:
-0.86%
JNJ
|
News
|
$149.12
0.82%
0.3%
7.2M
|
Health Technology
|
-10.08%
|
O:
-1.1%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.59
2.11%
0.57%
3.5M
|
Health Technology
|
16.14%
|
O:
-0.31%
H:
0.6%
C:
-1.06%
ATR
|
$140.32
0.7%
0.0%
300K
|
Process Industries
|
13.72%
|
O:
0.08%
H:
1.6%
C:
1.31%
MMM
|
$92.62
0.38%
0.0%
2.3M
|
Producer Manufacturing
|
-7.05%
|
O:
-0.38%
H:
1.41%
C:
-0.78%
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
1.49%
|
O:
-0.39%
H:
0.46%
C:
-1.37%
drug
reach
global
technology
market
Pharmacogenomics Industry Landscape 2023-2027: Personalized Medicine Propels Growth, Global Market Set for Robust Expansion
Published:
2023-08-22
(Crawled : 00:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
1.86%
-4.19%
3.6K
|
Health Technology
|
2.16%
|
O:
0.51%
H:
2.1%
C:
2.1%
QGEN
|
$41.22
3.05%
0.0%
1.2M
|
Health Technology
|
-6.92%
|
O:
0.25%
H:
1.26%
C:
0.92%
INFY
|
$17.3
2.92%
0.0%
19M
|
Technology Services
|
1.82%
|
O:
0.53%
H:
1.23%
C:
1.11%
BIO
|
$280.13
0.14%
0.0%
220K
|
Health Technology
|
-26.1%
|
O:
0.25%
H:
1.63%
C:
1.56%
BDX
|
$233.88
-0.1%
0.0%
770K
|
Health Technology
|
-15.27%
|
O:
0.11%
H:
0.0%
C:
0.0%
A
|
$133.91
0.89%
0.0%
850K
|
Health Technology
|
13.25%
|
O:
0.23%
H:
0.54%
C:
0.52%
ABT
|
News
|
$107.07
-0.2%
-0.09%
3.8M
|
Health Technology
|
3.11%
|
O:
1.73%
H:
0.0%
C:
0.0%
QGEN
|
$41.22
3.05%
0.0%
1.2M
|
Health Technology
|
-6.92%
|
O:
0.25%
H:
1.26%
C:
0.92%
MYGN
|
$18.49
-0.05%
-0.11%
490K
|
Health Technology
|
6.45%
|
O:
0.75%
H:
3.83%
C:
3.54%
ILMN
|
$120.25
2.4%
2.37%
940K
|
Health Technology
|
-27.77%
|
O:
-1.47%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
1.98%
|
O:
-0.16%
H:
0.79%
C:
0.64%
expansion
global
set
market
Global Diabetes Drugs Market to Reach $106.65 Billion by 2028: Rising Prevalence of Diabetes Fuels Growth
Published:
2023-08-21
(Crawled : 16:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-13.9%
|
O:
-0.02%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.73
1.86%
-4.19%
3.6K
|
Health Technology
|
1.98%
|
O:
0.16%
H:
0.51%
C:
0.51%
NVS
|
News
|
$95.12
0.81%
5.43%
2.3M
|
Health Technology
|
-6.19%
|
O:
1.5%
H:
0.52%
C:
0.43%
JNJ
|
News
|
$149.12
0.82%
0.3%
7.2M
|
Health Technology
|
-13.98%
|
O:
-2.16%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-12.87%
|
O:
1.17%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
2.44%
|
O:
0.76%
H:
0.23%
C:
-0.14%
reach
global
diabetes
growth
market
Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
Published:
2023-08-14
(Crawled : 20:00)
- globenewswire.com
DERM
|
$3.54
1.72%
1.42%
38K
|
|
62.39%
|
O:
-2.75%
H:
4.01%
C:
-0.47%
AZNCF
|
News
|
$138.73
1.86%
-4.19%
3.6K
|
Health Technology
|
-3.12%
|
O:
-1.75%
H:
0.0%
C:
-2.23%
MBIO
|
$0.34
-0.47%
9.7%
300K
|
Health Technology
|
-91.56%
|
O:
0.0%
H:
0.07%
C:
-5.71%
FBIO
|
$1.75
0.57%
150K
|
Health Technology
|
225.28%
|
O:
-8.92%
H:
0.0%
C:
0.0%
CKPT
|
$1.45
-0.69%
-1.39%
460K
|
Health Technology
|
-30.62%
|
O:
-0.96%
H:
2.42%
C:
-2.42%
ATXI
|
$0.1301
0.08%
1.66%
1.6M
|
Health Technology
|
-87.31%
|
O:
-2.37%
H:
4.0%
C:
0.0%
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
-1.0%
|
O:
-1.27%
H:
0.26%
C:
-0.61%
biotech
financial
results
Statkraft and AstraZeneca sign agreement on wind power delivery
Published:
2023-08-09
(Crawled : 07:00)
- globenewswire.com
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
0.52%
|
O:
1.61%
H:
0.95%
C:
0.55%
agreement
Antithrombotic drugs market size to grow by USD 23,199.94 million from 2022 to 2027: The growing prevalence of coagulation disorders drives growth - Technavio
Published:
2023-08-09
(Crawled : 00:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
0.52%
-14.18%
630
|
Health Technology
|
18.43%
|
O:
1.92%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$95.11
5.4%
6.88%
490
|
Health Technology
|
14.58%
|
O:
1.11%
H:
0.53%
C:
0.53%
VTRS
|
News
A
|
$11.235
-0.13%
-0.13%
5.1M
|
Health Technology
|
0.9%
|
O:
0.0%
H:
2.96%
C:
0.99%
NVS
|
News
|
$95.12
0.81%
5.43%
2.3M
|
Health Technology
|
-8.03%
|
O:
-0.07%
H:
0.73%
C:
0.36%
GSK
|
News
|
$40.59
2.11%
0.57%
3.5M
|
Health Technology
|
16.04%
|
O:
0.14%
H:
0.8%
C:
0.43%
ABBV
|
News
|
$167.89
0.89%
0.0%
5.6M
|
Health Technology
|
11.32%
|
O:
-0.16%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-11.38%
|
O:
0.81%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
0.52%
|
O:
1.61%
H:
0.95%
C:
0.55%
disorders
growing
growth
market
Fortress Biotech to Present at the BTIG Virtual Biotechnology Conference 2023
Published:
2023-08-03
(Crawled : 12:20)
- globenewswire.com
AZNCF
|
News
|
$138.73
1.86%
-4.19%
3.6K
|
Health Technology
|
-0.28%
|
O:
-0.08%
H:
0.0%
C:
0.0%
FBIO
|
$1.75
0.57%
150K
|
Health Technology
|
199.66%
|
O:
1.2%
H:
1.52%
C:
-4.99%
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
-0.74%
|
O:
-2.88%
H:
1.68%
C:
1.53%
conference
biotech
Global Adult Vaccine Market 2023: Rapid Growth in India with Increasing Awareness and Healthcare Measures
Published:
2023-07-28
(Crawled : 22:00)
- prnewswire.com
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.73
1.86%
-4.19%
3.6K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.305
0.52%
-14.18%
630
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$40.59
2.11%
0.57%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
vaccine
rapid
india
global
growth
market
ENHERTU® (fam-trastuzumab deruxtecan-nxki) Demonstrated Clinically Meaningful Progression-Free Survival and Overall Survival Across Multiple HER2-Expressing Advanced Solid Tumors in DESTINY-PanTumor02 Phase II Trial
Published:
2023-07-27
(Crawled : 12:00)
- biospace.com/
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
2.47%
|
O:
0.42%
H:
0.55%
C:
-0.86%
enhertu
tumors
trial
ENHERTU® Demonstrated Clinically Meaningful Progression-Free Survival and Overall Survival Across Multiple HER2 Expressing Advanced Solid Tumors in DESTINY-PanTumor02 Phase 2 Trial
Published:
2023-07-27
(Crawled : 10:00)
- biospace.com/
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
2.47%
|
O:
0.42%
H:
0.55%
C:
-0.86%
enhertu
her2
tumors
trial
Tyrosine Kinase Inhibitors Market size to grow by USD 24.12 billion from 2022 to 2027 | High target affinity and specificity of tyrosine kinase inhibitors boost the market growth - Technavio
Published:
2023-07-26
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
0.52%
-14.18%
630
|
Health Technology
|
12.59%
|
O:
2.38%
H:
2.49%
C:
2.49%
AZNCF
|
News
|
$138.73
1.86%
-4.19%
3.6K
|
Health Technology
|
-1.26%
|
O:
-0.04%
H:
0.0%
C:
0.0%
VTRS
|
News
A
|
$11.235
-0.13%
-0.13%
5.1M
|
Health Technology
|
7.35%
|
O:
-0.24%
H:
0.48%
C:
-1.2%
NVS
|
News
|
$95.12
0.81%
5.43%
2.3M
|
Health Technology
|
-8.78%
|
O:
0.7%
H:
0.12%
C:
-0.76%
GSK
|
News
|
$40.59
2.11%
0.57%
3.5M
|
Health Technology
|
13.16%
|
O:
1.03%
H:
0.39%
C:
-1.02%
ABBV
|
News
|
$167.89
0.89%
0.0%
5.6M
|
Health Technology
|
18.68%
|
O:
2.13%
H:
4.77%
C:
3.02%
PBYI
|
$5.17
3.19%
3.09%
270K
|
Health Technology
|
47.29%
|
O:
0.28%
H:
0.85%
C:
-1.99%
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
2.47%
|
O:
0.42%
H:
0.55%
C:
-0.86%
AMGN
|
News
|
$271.91
1.11%
1.12%
1.4M
|
Health Technology
|
15.6%
|
O:
-0.31%
H:
1.71%
C:
0.67%
growth
market
Nanotechnology Drug Delivery Market to Reach $209.5 Billion, Globally, by 2032 at 9.1% CAGR: Allied Market Research
Published:
2023-07-19
(Crawled : 09:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
1.86%
-4.19%
3.6K
|
Health Technology
|
3.18%
|
O:
0.47%
H:
1.47%
C:
1.47%
NVSEF
|
News
|
$95.11
5.4%
6.88%
490
|
Health Technology
|
9.52%
|
O:
-1.97%
H:
0.0%
C:
0.0%
TEVA
|
$12.88
0.16%
0.0%
7.9M
|
Health Technology
|
58.43%
|
O:
1.23%
H:
4.13%
C:
4.01%
NVS
|
News
|
$95.12
0.81%
5.43%
2.3M
|
Health Technology
|
-8.4%
|
O:
0.61%
H:
0.6%
C:
-0.84%
BMY
|
$49.14
0.43%
0.12%
6.4M
|
Health Technology
|
-20.74%
|
O:
0.19%
H:
1.19%
C:
-0.1%
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
5.03%
|
O:
1.5%
H:
0.75%
C:
-0.32%
AMGN
|
News
|
$271.91
1.11%
1.12%
1.4M
|
Health Technology
|
16.92%
|
O:
0.18%
H:
0.67%
C:
-0.4%
drug
reach
research
market
Text Analytics Market to grow at a CAGR of 19.82% from 2022 to 2027 | Alphabet Inc. Averbis GmbH Bitext Innovations SL Forsta AS Infegy InMoment Inc. and more to emerge as key players- Technavio
Published:
2023-07-14
(Crawled : 13:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
1.86%
-4.19%
3.6K
|
Health Technology
|
3.84%
|
O:
6.03%
H:
-2.14%
C:
-2.14%
SAPGF
|
News
|
$174.2277
-19.46%
21K
|
Technology Services
|
23.78%
|
O:
-0.34%
H:
1.8%
C:
1.29%
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
-34.32%
|
O:
0.96%
H:
0.0%
C:
-1.71%
SAP
|
News
|
$178.18
1.37%
0.18%
1M
|
Technology Services
|
23.77%
|
O:
0.06%
H:
0.6%
C:
0.22%
ABT
|
News
|
$107.07
-0.2%
-0.09%
3.8M
|
Health Technology
|
-0.62%
|
O:
0.24%
H:
0.44%
C:
-0.06%
NICE
|
News
|
$224.42
0.1%
0.28%
260K
|
Technology Services
|
7.32%
|
O:
-0.01%
H:
0.96%
C:
-1.5%
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
3.57%
|
O:
1.79%
H:
0.0%
C:
-2.23%
GOOGL
|
News
S
|
$156.28
1.42%
1.41%
20M
|
Technology Services
|
25.49%
|
O:
0.21%
H:
1.58%
C:
0.5%
GOOG
|
News
S
|
$157.95
1.43%
1.42%
12M
|
Technology Services
|
26.53%
|
O:
0.24%
H:
1.57%
C:
0.46%
analytics
market
Vaccine research market to grow at a CAGR of 9.88% from 2022 to 2027 | Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players- Technavio
Published:
2023-07-14
(Crawled : 11:00)
- prnewswire.com
CSLLY
|
$89.17
2.7%
3.3%
54K
|
n/a
|
-1.89%
|
O:
-0.54%
H:
0.0%
C:
-1.4%
GLAXF
|
News
|
$20.305
0.52%
-14.18%
630
|
Health Technology
|
15.01%
|
O:
0.0%
H:
1.42%
C:
0.96%
AZNCF
|
News
|
$138.73
1.86%
-4.19%
3.6K
|
Health Technology
|
3.84%
|
O:
6.03%
H:
-2.14%
C:
-2.14%
ALPMY
|
News
|
$9.53
0.32%
-1.11%
690K
|
Manufacturing
|
-34.32%
|
O:
0.96%
H:
0.0%
C:
-1.71%
GSK
|
News
|
$40.59
2.11%
0.57%
3.5M
|
Health Technology
|
16.64%
|
O:
0.03%
H:
0.2%
C:
-0.8%
ABT
|
News
|
$107.07
-0.2%
-0.09%
3.8M
|
Health Technology
|
-0.62%
|
O:
0.24%
H:
0.44%
C:
-0.06%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-11.89%
|
O:
0.36%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
3.57%
|
O:
1.79%
H:
0.0%
C:
-2.23%
pharma
vaccine
research
market
American Red Cross Elects Aradhana Sarin as New Member to National Board of Governors
Published:
2023-07-13
(Crawled : 14:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
1.86%
-4.19%
3.6K
|
Health Technology
|
3.28%
|
O:
-0.24%
H:
0.0%
C:
-0.3%
AZN
|
News
|
$70.13
2.31%
2.24%
4.3M
|
Health Technology
|
5.51%
|
O:
1.47%
H:
0.52%
C:
0.39%
← Previous
1
2
3
4
5
6
7
8
9
10
11
12
…
33
34
Next →
Gainers vs Losers
74%
26%
Top 10 Gainers
MTTR
|
News
M
|
$4.8
175.86%
63.6%
71M
|
AGBA
|
$2.5
100.0%
56.6%
200M
|
Finance
MLEC
|
$2.47
76.43%
42.62%
78M
|
n/a
NUWE
|
$0.334
29.96%
40.99%
2.5M
|
Manufacturing
EDBL
|
News
|
$6.26
66.49%
40.13%
16M
|
ATGL
|
$2.86
46.25%
32.8%
180K
|
ZAPP
|
$0.2175
47.16%
32.05%
16M
|
n/a
ONFO
|
$0.6088
38.68%
27.74%
7.3M
|
n/a
VIVK
|
$1.48
38.32%
27.7%
530K
|
Professional, Scientific, and T...
MNTS
|
$0.5
35.69%
26.3%
4.7M
|
Your saved searches
Save your searches and get alerts when important news are released.